[go: up one dir, main page]

SE9804003D0 - A method of producing drug particles - Google Patents

A method of producing drug particles

Info

Publication number
SE9804003D0
SE9804003D0 SE9804003A SE9804003A SE9804003D0 SE 9804003 D0 SE9804003 D0 SE 9804003D0 SE 9804003 A SE9804003 A SE 9804003A SE 9804003 A SE9804003 A SE 9804003A SE 9804003 D0 SE9804003 D0 SE 9804003D0
Authority
SE
Sweden
Prior art keywords
drug particles
producing drug
producing
susceptible
degradation
Prior art date
Application number
SE9804003A
Other languages
English (en)
Swedish (sv)
Inventor
Catherine Boissier
Anne Mari Juppo
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9804003A priority Critical patent/SE9804003D0/xx
Publication of SE9804003D0 publication Critical patent/SE9804003D0/xx
Priority to PCT/SE1999/002152 priority patent/WO2000030612A1/fr
Priority to AU20102/00A priority patent/AU754385B2/en
Priority to US09/486,688 priority patent/US6596315B1/en
Priority to PT99963729T priority patent/PT1133283E/pt
Priority to AT99963729T priority patent/ATE278390T1/de
Priority to JP2000583496A priority patent/JP4612191B2/ja
Priority to DE69920945T priority patent/DE69920945T2/de
Priority to ES99963729T priority patent/ES2228148T3/es
Priority to EP99963729A priority patent/EP1133283B1/fr
Priority to DK99963729T priority patent/DK1133283T3/da
Priority to CA002349711A priority patent/CA2349711C/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9804003A 1998-11-23 1998-11-23 A method of producing drug particles SE9804003D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles
CA002349711A CA2349711C (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
PT99963729T PT1133283E (pt) 1998-11-23 1999-11-22 Um metodo de producao de particulas de farmaco
AU20102/00A AU754385B2 (en) 1998-11-23 1999-11-22 A method of producing drug particles
US09/486,688 US6596315B1 (en) 1998-11-23 1999-11-22 Method of producing drug particles
PCT/SE1999/002152 WO2000030612A1 (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
AT99963729T ATE278390T1 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
JP2000583496A JP4612191B2 (ja) 1998-11-23 1999-11-22 薬物粒子の製造方法
DE69920945T DE69920945T2 (de) 1998-11-23 1999-11-22 Verfahren zur herstellung von arzneistoffpartikeln
ES99963729T ES2228148T3 (es) 1998-11-23 1999-11-22 Metodo de produccion de particulas de farmacos.
EP99963729A EP1133283B1 (fr) 1998-11-23 1999-11-22 Procede de production de particules medicamenteuses
DK99963729T DK1133283T3 (da) 1998-11-23 1999-11-22 Fremgangsmåde til fremstilling af lægemiddelpartikler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Publications (1)

Publication Number Publication Date
SE9804003D0 true SE9804003D0 (sv) 1998-11-23

Family

ID=20413380

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804003A SE9804003D0 (sv) 1998-11-23 1998-11-23 A method of producing drug particles

Country Status (12)

Country Link
US (1) US6596315B1 (fr)
EP (1) EP1133283B1 (fr)
JP (1) JP4612191B2 (fr)
AT (1) ATE278390T1 (fr)
AU (1) AU754385B2 (fr)
CA (1) CA2349711C (fr)
DE (1) DE69920945T2 (fr)
DK (1) DK1133283T3 (fr)
ES (1) ES2228148T3 (fr)
PT (1) PT1133283E (fr)
SE (1) SE9804003D0 (fr)
WO (1) WO2000030612A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2290893C (fr) 1999-11-16 2007-05-01 Bernard Charles Sherman Omeprazole de magnesium
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
AU2002221320B2 (en) * 2000-12-08 2006-06-15 The University Of Sydney Synthesis of small particles
AUPR197000A0 (en) * 2000-12-08 2001-01-11 Unisearch Limited Synthesis of small particles
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7186796B2 (en) 2002-02-25 2007-03-06 Phasex Corporation Method for drying water-borne materials
US7862751B2 (en) 2002-04-15 2011-01-04 Map Pharmaceuticals, Inc. Formulation of fine particles using liquefield or dense gases
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
CA2501424A1 (fr) 2002-08-30 2004-03-11 Dr. Reddy's Laboratories Limited Hydrates amorphes d'esomeprazole magnesium et leur procede de preparation
WO2004046134A2 (fr) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Composes d'esomeprazole cristallins et procede permettant de preparer ces composes
GB2401547B (en) 2003-05-08 2005-07-20 Nektar Therapeutics Uk Ltd Particulate materials
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2007009164A1 (fr) 2005-07-15 2007-01-25 Eiffel Technologies Limited Procede de formation de particules
EP2026768B1 (fr) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Formulation pharmaceutique comprenant des unités multiples
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
CA2767773C (fr) 2011-02-11 2015-11-24 Grain Processing Corporation Composition comprenant un sel et un agent d'interruption de cristallisation
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
WO1990003782A2 (fr) * 1988-10-05 1990-04-19 The Upjohn Company Poudres cristallines solides finement divisees par une precipitation dans un anti-solvant
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
KR100508910B1 (ko) * 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer

Also Published As

Publication number Publication date
ATE278390T1 (de) 2004-10-15
AU754385B2 (en) 2002-11-14
PT1133283E (pt) 2005-01-31
JP4612191B2 (ja) 2011-01-12
EP1133283A1 (fr) 2001-09-19
CA2349711A1 (fr) 2000-06-02
DE69920945T2 (de) 2005-08-25
DK1133283T3 (da) 2005-01-24
WO2000030612A1 (fr) 2000-06-02
DE69920945D1 (de) 2004-11-11
JP2002530317A (ja) 2002-09-17
AU2010200A (en) 2000-06-13
ES2228148T3 (es) 2005-04-01
CA2349711C (fr) 2008-07-15
US6596315B1 (en) 2003-07-22
EP1133283B1 (fr) 2004-10-06

Similar Documents

Publication Publication Date Title
SE9804003D0 (sv) A method of producing drug particles
AU2002320317A1 (en) Novel mesogens and methods for their synthesis and use
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
DE69006143D1 (de) Hochdruckgaszufuhrsystem.
NO990596D0 (no) FremgangsmÕte for drift av en olje- og gassproduksjonsbr°nn aktivisert av et pumpesystem
DK0859766T3 (da) Chirale methylphenyloxazolidinoner
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
TR199800608A3 (tr) Propanolamin türevleri, bunlarin üretim usulü.
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
IL154776A0 (en) Method for the preparation of 21-hydroxy-6, 19-oxidoprogesterone and derivatives thereof
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
PL362392A1 (pl) Sposób wytwarzania pochodnych taksanu
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
WO2001049651A3 (fr) Derives d'aminomethyle-phenyle-cyclohexane
PL338147A1 (en) Derivatives of polyhydroxylbutylpyrazine, method of obtaining and drugs containing them
PL367981A1 (en) A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
TR199801514A3 (tr) N-Piruvil-L-Prolin üretimi için yöntem.